Stem Cell Authority, Ltd. (SCAL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 9, 2026
Stem Cell Authority Revenue
In the fiscal year ending August 31, 2009, Stem Cell Authority had annual revenue of $3.33M with 11,044.25% growth. Stem Cell Authority had revenue of $601.01K in the half year ending July 31, 2007. That makes Stem Cell Authority the 41,188th largest company in the world by revenue and 5,535th in the United States.
Revenue
3.33M
Revenue Growth
+11,044.25%
P/S Ratio
0.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.44M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2009 | 3.33M | 3.30M | 11,044.25% |
| Aug 31, 2008 | 29.86K | -1.10M | -97.35% |
| Aug 31, 2007 | 1.13M | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | - | - | - |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aesthetic Medical International Holdings Group | 103.35M |
| Regional Health Properties | 80.80M |
| Veltex | 70.13M |
| Yuka Group | 7.84M |
| Numinus Wellness | 4.97M |
| HealthLynked | 1.37M |
| BioCorRx | 651.15K |
| Dental Patient Care America | 475.52K |